Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Worldwide Bacteriophage Industry to 2026 - Research to Establish Bacteriophage as An Effective Vaccine Delivery System Presents Opportunities


DUBLIN, July 23, 2021 /PRNewswire/ -- The "Bacteriophage Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The report on the global bacteriophage market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global bacteriophage market to grow with a CAGR of 4.3% over the forecast period from 2020-2026. The study on bacteriophage market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on bacteriophage market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global bacteriophage market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global bacteriophage market over the period of 2018 to 2026. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

2) Restraints

3) Opportunities

Segment Covered
The global bacteriophage market is segmented on the basis of type, and application.

The Global Bacteriophage Market by Type

The Global Bacteriophage Market by Application

What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the bacteriophage market.
2. Complete coverage of all the segments in the bacteriophage market to analyze the trends, developments in the global market and forecast of market size up to 2026.
3. Comprehensive analysis of the companies operating in the global bacteriophage market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Bacteriophage Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Bacteriophage Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Type
3.5.2. Growth Matrix Analysis by Application
3.5.3. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Bacteriophage Market

4. Bacteriophage Market Macro Indicator Analysis

5. Global Bacteriophage Market by Type
5.1. dsDNA Bacteriophage
5.2. ssDNA Bacteriophage
5.3. ssRNA Bacteriophage

6. Global Bacteriophage Market by Application
6.1. Clinical Application
6.2. Phage Display
6.3. Environmental Application
6.4. Veterinary
6.5. Phage Therapy

7. Global Bacteriophage Market by Region 2020-2026
7.1. North America
7.1.1. North America Bacteriophage Market by Type
7.1.2. North America Bacteriophage Market by Application
7.1.3. North America Bacteriophage Market by Country
7.2. Europe
7.2.1. Europe Bacteriophage Market by Type
7.2.2. Europe Bacteriophage Market by Application
7.2.3. Europe Bacteriophage Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Bacteriophage Market by Type
7.3.2. Asia-Pacific Bacteriophage Market by Application
7.3.3. Asia-Pacific Bacteriophage Market by Country
7.4. RoW
7.4.1. RoW Bacteriophage Market by Type
7.4.2. RoW Bacteriophage Market by Application
7.4.3. RoW Bacteriophage Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Bacteriophage Market
8.2. Companies Profiled
8.2.1. Phage Biotech Ltd.
8.2.2. Fixed-Phage Limited
8.2.3. InnoPhage Ltd.
8.2.4. EnBiotix Inc.
8.2.5. Pherecydes Pharma SA
8.2.6. TechnoPhage SA
8.2.7. Versatile Bio Fuels Pvt. Ltd.
8.2.8. Federal State Scientific Industrial Company MICROGEN
8.2.9. Intralytix, Inc.
8.2.10. AmpliPhi Biosciences Corporation

For more information about this report visit https://www.researchandmarkets.com/r/k8djrt

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]      

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Walgreens Boots Alliance, Inc. today announced financial results for the second quarter of fiscal 2024, which ended February 29, 2024. Chief Executive Officer Tim Wentworth said: "We're encouraged by our first quarter of U.S. Healthcare positive...

at 07:05
Gilead Sciences, Inc. and Xilio Therapeutics, Inc. today announced an exclusive license agreement to develop and commercialize Xilio's Phase 1 tumor-activated IL-12 program, XTX301. Xilio Therapeutics is a clinical-stage biotechnology company...

at 07:05
Mannatech, Incorporated , a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and year ended December 31, 2023. Fourth Quarter Highlights Fourth...

at 07:00
Mayfair Gold Corp. ("Mayfair" or the "Company") today announced the start the 2024 environmental field program in support of a potential environmental assessment for the 100% controlled Fenn-Gib project in the Timmins region of Ontario. The program...

at 07:00
OneSoft Solutions Inc. (the "Company" or "OneSoft") , a North American developer of cloud-based business solutions, announces that it will release its Fiscal 2023 financial results after market close on April 1, 2024.OneSoft's CEO...



News published on and distributed by: